Kirk Campbell

Kirk Campbell, MD is an Adjunct Professor in the Department of Nephrology at Mount Sinai School of Medicine, and a Professor of Pharmacological Sciences. He serves as the inaugural Director of the Mount Sinai Center for Kidney Disease Innovation, integrating clinical programs in glomerular disease, polycystic kidney disease, onco-nephrology, and diabetic kidney disease into translational research frameworks.

• Medical degree from the University of Connecticut
• Internal medicine residency at Yale University
• Clinical nephrology and postdoctoral training at Mount Sinai

His research focuses on elucidating signaling pathways regulating kidney podocyte injury and survival to identify novel therapeutic targets for glomerular diseases. Key areas include

• Translational and precision medicine
• Genomics and molecular phenotyping
• Drug discovery for proteinuric kidney diseases
• Biomarker validation

He has received multiple honors, including

• Distinguished Leader Award from the American Society of Nephrology
• Harrington Discovery Institute Scholar Innovator grant
• Membership in the American Society for Clinical Investigation

As principal investigator of Mount Sinai’s NIH-funded Kidney Precision Project Recruitment Site, he leads efforts in personalized treatment development. He also contributes to editorial boards of leading journals like American Journal of Kidney Disease and Kidney International. His lab website is The Campbell Laboratory.